KI-DX-014
KI-DX-014 is a DDX21 inhibitor with an IC50 of 3.31 μM. KI-DX-014 significantly inhibits the DDX21-RNA interaction and modulates ATPase activity and biomolecular condensate formation. KI-DX-014 reduces the DDX21-dependent release of P-TEFb from the 7SK snRNP complex, inhibits P-TEFb-dependent phosphorylation of the RNA polymerase II CTD, and induces developmental defects in zebrafish embryos. KI-DX-014 can be used for cancers and neurodegenerative disorders research[1].
Product Specifications
CAS Number
1309288-83-2
UNSPSC
12352005
Target
ATP Synthase; DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel
Field of Research
Cancer; Neurological Disease
Purity
98.5600
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=CC=C(C=C1)N2N=CC(CN3CCC(C(O)=O)(C3)N)=C2C
Molecular Formula
C17H22N4O3
Molecular Weight
330.38
References & Citations
[1]Aiba T, et al. Chemical Probe Discovery for DEAD-Box RNA-Binding Protein DDX21 Using Small-Molecule Microarrays. ACS Chem Biol. 2025 Jul 10.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Salivary alpha amylase (AMY1A) Rabbit Polyclonal Antibody
